AC Immune SA (ACIU)
4.03
-0.07
(-1.71%)
USD |
NASDAQ |
Jun 21, 16:00
4.03
0.00 (0.00%)
After-Hours: 16:31
AC Immune Accounts Receivable (Quarterly): 0.00 for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 17.62M |
September 30, 2023 |
Date | Value |
---|---|
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2022
17.62M
Maximum
Dec 2023
5.873M
Average
--
Median
Dec 2022
Accounts Receivable (Quarterly) Benchmarks
CRISPR Therapeutics AG | 0.00 |
Addex Therapeutics Ltd | 0.1288M |
NLS Pharmaceutics Ltd | -- |
Molecular Partners AG | 3.523M |
MoonLake Immunotherapeutics | -- |